U.S. regulators are trying to shut down the industry for compounded weight-loss drugs, which could result in higher costs or ...

As discussions unfold, Kennedy seeks to balance drug accessibility with concerns about the long-term costs of providing GLP-1 ...

Ozempic is not marketed as a weight loss drug and is prescribed to those with type 2 diabetes to help manage their condition ...

The Medicare Rights Center reports that President Trump’s executive order on prescription drug pricing supports key drug ...

The wide-ranging executive order signed by Trump aims to reduce healthcare costs. It comes one day after the Trump ...

“Currently, Medicare covers these drugs only under specific circumstances ... noted that semaglutides, including Ozempic and ...

President Donald Trump signed an executive order on the healthcare sector yesterday, aiming to lower prescription drug prices ...

Pa., said Mounjaro changed his life with 'significant' health benefits. He's calling for widespread access to GLP-1 ...

Pennsylvania doctor Neil Anand, MD, was convicted for illegally doling out "goody bags" of prescription drugs that patients ...

Some of the more than a dozen states that cover GLP-1 drugs like Wegovy, Ozempic and Zepbound through Medicaid are scrambling ...

A surprise executive order could delay drug price cuts and supercharge profits for the industry's biggest players ...

The U.S. Food and Drug Administration on Monday warned consumers and pharmacies that fake versions of Ozempic, a drug to ...